Please provide your email address to receive an email when new articles are posted on . Use of a single inhaler with albuterol and corticosteroids as needed reduced exacerbations by 26%. As-needed ...

What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

A single combined-drug inhaler used as needed protects adults with mild asthma from worsening illness and hospital stays, a recent commentary on Cochrane systematic review data reports. But long-term ...

Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

Three studies have shown that doubling the dose of ICS is not effective for treatment of exacerbations. Several studies have shown benefit from high dose ICS (2400-4000ìg beclomethasone equivalent) ...

These findings challenge national and international medical guidelines, particularly in the USA, where this approach has yet to be approved. Despite effective drug treatment options, most adults with ...

Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not ...

Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...

Low number of patients treated based on the Single Maintenance and Reliever Therapy (SMART) guideline. HealthDay News — Only 14.5% of adult patients with moderate or severe asthma are prescribed the ...